Dense deposit disease: a variant of membranoproliferative glomerulonephritis
about
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient miceVariations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNTranslational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.Dense deposit disease: clinicopathologic study of 32 pediatric and adult patientsTreatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab.A case of regression of atypical dense deposit disease without C3 deposition in a child.Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceCurrent concepts in C3 glomerulopathy.Dense deposit disease.Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.Causes of alternative pathway dysregulation in dense deposit disease.Interstitial nephritis induced by protein-overload proteinuria.Lectin binding in membranoproliferative glomerulonephritis. Evidence for N-acetylglucosamine in dense intramembranous depositsMembranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.New approaches to the treatment of dense deposit disease.Dense deposit disease and C3 glomerulopathyC3 glomerulopathy: a new classification.Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.Recent insights into C3 glomerulopathyHistopathology of MPGN and C3 glomerulopathies.Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.Retinal disease in the C3 glomerulopathies and the risk of impaired vision.Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.Circulating and deposited immune complexes in renal disease and their clinical correlation.Thickening of glomerular capillary walls: a guide to differential diagnosis by electron microscopy.C3 glomerulopathy and current dilemmas.Management of membranoproliferative glomerulonephritis type II with plasmapheresis.Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.Long-term prognosis in idiopathic membranoproliferative glomerulonephritis.Familial Nephropathy in Bernese Mountain Dogs
P2860
Q24651118-81EB040B-B94F-4799-94C4-71B73B0E527CQ24655016-214AEC22-16BC-4208-B144-FD01DDDF533EQ26741542-63E74BA9-359D-4313-B565-FC260324E132Q33377727-EA8E9029-DC3C-494C-95BC-0A1701163941Q33378236-3804D70A-CAFA-4041-93D7-94307B227B42Q33381183-E109B8BA-6138-49DC-9D2C-76FA89266E12Q33743019-FD0ADD9A-188A-4551-A2B1-B0DA5B6155ADQ34417351-3ECD89A6-F923-4AC8-81E8-67AEDBED55BCQ34537391-E3674EE7-4571-4FE5-820F-806089D8E813Q34574482-E853E35A-B979-4DC3-8592-597C7EE77326Q35124165-38C079A7-E2F3-4111-9BBD-D57E6CD55A8DQ35246525-490EF170-4F8F-44EE-953E-80A83D314766Q35758595-640856B6-194D-4A6C-BE0F-C3DBC81180E5Q35817159-FD7D8A01-2FCB-4876-94F1-3B846F8F2F89Q35834946-CF8F26D3-C270-4EA0-A59C-5B43FFDEF7C7Q36077915-04A92547-2B93-42E5-BB2A-AEDB6B6C4570Q36860946-A7BFB932-2424-4466-A44B-6632BA8948F1Q37286653-7AFFA4ED-ABFC-4CF9-8830-C333CEC516A6Q37770399-B9BC7194-338C-48A1-9203-E8836B46987BQ38048606-63026053-E2D3-4031-963F-63369D7E25F3Q38088187-6D5FA67B-A32A-4695-8DC7-0D93B6F272A8Q38275117-5F0A44CB-4698-4B36-B4EE-3ADCC6EA8CF1Q38749694-C473CB05-196E-407D-87C3-40BC0AFECF8EQ38749961-03B24BF8-A0D6-4610-9CB6-D135B02C8C7DQ38880897-85B7F877-051C-4186-8A74-C8D7B6AB2172Q39902516-BA072406-F874-431D-88D2-F2A927D0E903Q40273695-F5AB64A5-6773-4CA1-B599-D279F720236CQ40439038-891CF1AE-4B5A-4292-966D-A418EE9CA859Q44178408-DBD952C6-7F46-4DC1-85A6-BF6E67513C23Q44886223-568456CE-D2BC-4ED6-968E-17FE396CD375Q51039813-4904FE77-EFBA-4586-9A66-21B845396C45Q57607250-7ABB3AA3-4F3D-4DA5-9728-24F52C65CA3F
P2860
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
description
1975 nî lūn-bûn
@nan
1975 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@ast
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@en
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@nl
type
label
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@ast
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@en
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@nl
prefLabel
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@ast
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@en
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@nl
P2093
P356
P1433
P1476
Dense deposit disease: a variant of membranoproliferative glomerulonephritis
@en
P2093
P2888
P304
P356
10.1038/KI.1975.32
P407
P577
1975-04-01T00:00:00Z
P6179
1009561042